Roger S. McIntyre, MD, FRCPC
Assoc. Professor, Dept of Psychiatry & Pharmacology,
University of Toronto
Assoc. Professor, Dept of Psychiatry & Pharmacology,
University of Toronto
Research Interests
Dr. Roger McIntyre is currently an Associate Professor of Psychiatry and Pharmacology at the University
of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network,
Toronto, Canada.
Dr. McIntyre is involved in multiple research endeavours which primarily aim to characterize the
association between mood disorders and medical comorbidity. This research involves elucidating
metabolic adverse events associated with the use of psychotropic medications, the impact of medical
comorbidity on the course of mood disorders, and the effect of glucose homeostasis on neurocognition.
Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both
national and international meetings. He has received several teaching awards from the University of
Toronto, Department of Psychiatry and was awarded the joint Canadian Psychiatric Association (CPA) /
Council of Psychiatric Continuing Education 2000-2001 Award for the Most Outstanding Continuing
Education Activity in Psychiatry in Canada.
Dr. McIntyre is a contributor to the CPA guidelines for the treatment of depressive disorders and the
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of
bipolar disorder. Dr. McIntyre has published extensively in leading peer-reviewed journals and
textbooks. Dr. McIntyre is also a reviewer for many journals including the American Journal of Psychiatry,
Biological Psychiatry, Journal of Clinical Psychiatry and The New England Journal of Medicine, and
serves as a grant reviewer for the National Institute of Mental Health.
Dr. McIntyre completed his medical degree at Dalhousie University. He received his Psychiatry residency
training and Fellowship in Psychiatric Pharmacology at the University of Toronto.
Dr. Roger McIntyre is currently an Associate Professor of Psychiatry and Pharmacology at the University
of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network,
Toronto, Canada.
Dr. McIntyre is involved in multiple research endeavours which primarily aim to characterize the
association between mood disorders and medical comorbidity. This research involves elucidating
metabolic adverse events associated with the use of psychotropic medications, the impact of medical
comorbidity on the course of mood disorders, and the effect of glucose homeostasis on neurocognition.
Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both
national and international meetings. He has received several teaching awards from the University of
Toronto, Department of Psychiatry and was awarded the joint Canadian Psychiatric Association (CPA) /
Council of Psychiatric Continuing Education 2000-2001 Award for the Most Outstanding Continuing
Education Activity in Psychiatry in Canada.
Dr. McIntyre is a contributor to the CPA guidelines for the treatment of depressive disorders and the
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of
bipolar disorder. Dr. McIntyre has published extensively in leading peer-reviewed journals and
textbooks. Dr. McIntyre is also a reviewer for many journals including the American Journal of Psychiatry,
Biological Psychiatry, Journal of Clinical Psychiatry and The New England Journal of Medicine, and
serves as a grant reviewer for the National Institute of Mental Health.
Dr. McIntyre completed his medical degree at Dalhousie University. He received his Psychiatry residency
training and Fellowship in Psychiatric Pharmacology at the University of Toronto.